Hanumantha Rao Madala
0000-0001-8086-3188
Publication & Citation Trends
Most Cited Works
Publications
93 total
Novel Pathways of Oxidative and Nitrosative Inactivation of the Human MGMT Protein in Colon Cancer and Glioblastoma Cells: Increased Efficacy of Alkylating Agents In Vitro and In Vivo OA
Cited by 0
Semantic Scholar
Development of GE8820 for Selective and Rapid Removal of Pathogenic Autoantibodies in Primary Membranous Nephritis (PMN) and Other IgG4-Mediated Diseases
Cited by 0
Semantic Scholar
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies PDF
Cited by 9
OpenAlex
Abstract 572: Tumor-activated PD1-directed IL-2 increased antigen specific T cells in tumors and demonstrated anti-tumor activity in mice
Cited by 1
Semantic Scholar
Abstract 587: A half-life extended, tumor-activated IL-12 increased the infiltration of effector immune cells into the tumor microenvironment and demonstrated anti-tumor activity in syngeneic mouse models
Cited by 0
Semantic Scholar
1056 XTX301, a tumor activated, half-life extended IL-12 promoted potent anti-tumor immunity and activity across multiple syngeneic tumor models OA
Cited by 0
Semantic Scholar
841 XTX202, a tumor-selective protein-engineered IL-2, exhibited enhanced anti-tumor activity in combination with checkpoint inhibition in mice OA
Cited by 1
Semantic Scholar
An Asp to Strike Out Cancer? Therapeutic Possibilities Arising from Aspartate’s Emerging Roles in Cell Proliferation and Survival PDF
Cited by 42
OpenAlex
719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates PDF
Cited by 4
OpenAlex
In Vivo Ear Sponge Lymphangiogenesis Assay.
Cited by 3
Semantic Scholar
Research Topics
Cytokine Signaling Pathways and Interactions
(44)
Cancer, Hypoxia, and Metabolism
(12)
Glioma Diagnosis and Treatment
(9)
Mitochondrial Function and Pathology
(7)
Cancer Immunotherapy and Biomarkers
(6)
Frequent Co-Authors
Affiliations
Texas Tech University
Harvard University
Massachusetts General Hospital
Xilio Therapeutics (United States)
Texas Tech University Health Sciences Center